Clinical Challenges in Diagnosis, Tumor Localization and Treatment of <scp>Tumor‐Induced</scp> Osteomalacia: Outcome of a Retrospective Surveillance-Reference-Cited by-同舟云学术

Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor‐Induced Osteomalacia: Outcome of a Retrospective Surveillance

Published:2022-07 Issue:8 Volume:37 Page:1479-1488
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Hidaka Naoko¹²^ORCID,Koga Minae¹²,Kimura Soichiro¹³,Hoshino Yoshitomo¹²,Kato Hajime¹²^ORCID,Kinoshita Yuka¹²^ORCID,Makita Noriko¹²,Nangaku Masaomi¹,Horiguchi Kazuhiko⁴,Furukawa Yasushi⁵,Ohnaka Keizo⁶,Inagaki Kenichi⁷,Nakagawa Atsushi⁸,Suzuki Atsushi⁹,Takeuchi Yasuhiro³,Fukumoto Seiji¹⁰,Nakatani Fumihiko¹¹,Ito Nobuaki¹²^ORCID

Affiliation:

1. Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan

2. Osteoporosis Center The University of Tokyo Hospital Tokyo Japan

3. Toranomon Hospital Endocrine Center, Toranomon Hospital Tokyo Japan

4. Division of Endocrinology and Metabolism, Department of Internal Medicine Gunma University Graduate School of Medicine Maebashi Japan

5. First Department of Internal Medicine Wakayama Medical University Wakayama Japan

6. Department of Geriatric Medicine Graduate School of Medical Sciences, Kyushu University Fukuoka Japan

7. Endocrine Center Okayama University Hospital Okayama Japan

8. Department of Diabetology and Endocrinology Kanazawa Medical University Kahoku Japan

9. Department of Endocrinology, Diabetes and Metabolism Fujita Health University Toyoake Japan

10. Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University Tokushima Japan

11. Department of Musculoskeletal Oncology National Cancer Center Hospital East Kashiwa Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4620

Reference40 articles.

1. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment

2. FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

3. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

4. Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia

5. Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up Data of Tumor-Induced Osteomalacia Managed with Surgery and/or Radiofrequency Ablation from a Single Center;Calcified Tissue International;2024-06-26

2. Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review;The Journal of Clinical Endocrinology & Metabolism;2024-06-24

3. Tumor-induced osteomalacia: A systematic literature review;Bone Reports;2024-06

4. Tumor-Induced Osteomalacia due to Sarcomatoid Non–Small Cell Lung Carcinoma Confounded by Drug-Induced Fanconi Syndrome;JCEM Case Reports;2024-05-24

5. Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3’-UTR change as a possible cause-;Bone;2024-05